{"description":"The initial dose of osimertinib/placebo 80 mg QD could be reduced to 40 mg QD to allow for management of study treatment-related toxicities. Once the dose of osimertinib/placebo was reduced to 40 mg QD, the patient was to remain on the reduced dose until termination from study treatment","eventGroups":[{"deathsNumAffected":28,"deathsNumAtRisk":143,"description":"80mg once daily tablet","id":"EG000","otherNumAffected":129,"otherNumAtRisk":143,"seriousNumAffected":55,"seriousNumAtRisk":143,"title":"Osimertinib"},{"deathsNumAffected":15,"deathsNumAtRisk":73,"description":"Matching Placebo","id":"EG001","otherNumAffected":54,"otherNumAtRisk":73,"seriousNumAffected":11,"seriousNumAtRisk":73,"title":"Placebo"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":143,"numEvents":20},{"groupId":"EG001","numAffected":2,"numAtRisk":73,"numEvents":2}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":143,"numEvents":16},{"groupId":"EG001","numAffected":3,"numAtRisk":73,"numEvents":3}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":28,"numAtRisk":143,"numEvents":28},{"groupId":"EG001","numAffected":6,"numAtRisk":73,"numEvents":6}],"term":"Covid-19"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":143,"numEvents":13},{"groupId":"EG001","numAffected":2,"numAtRisk":73,"numEvents":2}],"term":"Herpes zoster"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":143,"numEvents":9},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":143,"numEvents":29},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Paronychia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":143,"numEvents":10},{"groupId":"EG001","numAffected":3,"numAtRisk":73,"numEvents":5}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":143,"numEvents":18},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":143,"numEvents":13},{"groupId":"EG001","numAffected":2,"numAtRisk":73,"numEvents":2}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":55,"numAtRisk":143,"numEvents":55},{"groupId":"EG001","numAffected":26,"numAtRisk":73,"numEvents":27}],"term":"Radiation pneumonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":143,"numEvents":12},{"groupId":"EG001","numAffected":2,"numAtRisk":73,"numEvents":2}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":143,"numEvents":11},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":143,"numEvents":14},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":143,"numEvents":35},{"groupId":"EG001","numAffected":2,"numAtRisk":73,"numEvents":2}],"term":"White blood cell count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":143,"numEvents":23},{"groupId":"EG001","numAffected":4,"numAtRisk":73,"numEvents":4}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":143,"numEvents":12},{"groupId":"EG001","numAffected":6,"numAtRisk":73,"numEvents":7}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":143,"numEvents":5},{"groupId":"EG001","numAffected":9,"numAtRisk":73,"numEvents":9}],"term":"Musculoskeletal chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":143,"numEvents":5},{"groupId":"EG001","numAffected":6,"numAtRisk":73,"numEvents":7}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":143,"numEvents":2},{"groupId":"EG001","numAffected":4,"numAtRisk":73,"numEvents":4}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":143,"numEvents":29},{"groupId":"EG001","numAffected":7,"numAtRisk":73,"numEvents":7}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":143,"numEvents":9},{"groupId":"EG001","numAffected":5,"numAtRisk":73,"numEvents":5}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":143,"numEvents":7},{"groupId":"EG001","numAffected":4,"numAtRisk":73,"numEvents":4}],"term":"Productive cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":143,"numEvents":9},{"groupId":"EG001","numAffected":2,"numAtRisk":73,"numEvents":2}],"term":"Dermatitis acneiform"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":143,"numEvents":22},{"groupId":"EG001","numAffected":4,"numAtRisk":73,"numEvents":4}],"term":"Dry skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":143,"numEvents":20},{"groupId":"EG001","numAffected":5,"numAtRisk":73,"numEvents":5}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":34,"numAtRisk":143,"numEvents":40},{"groupId":"EG001","numAffected":10,"numAtRisk":73,"numEvents":11}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":143,"numEvents":12},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Sinus tachycardia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":51,"numAtRisk":143,"numEvents":67},{"groupId":"EG001","numAffected":10,"numAtRisk":73,"numEvents":11}],"term":"Diarrhoea"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Large intestine polyp"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":143,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Oesophageal stenosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":143,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Malaise"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Hepatic failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Bacterial pyelonephritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Biliary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Bronchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Covid-19"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Chronic hepatitis b"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Dengue fever"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":143,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Gastroenteritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Pneumocystis jirovecii pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":143,"numEvents":7},{"groupId":"EG001","numAffected":3,"numAtRisk":73,"numEvents":3}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":143,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Pneumonia aspiration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Pneumonia viral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Femur fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Meniscus injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":143,"numEvents":15},{"groupId":"EG001","numAffected":2,"numAtRisk":73,"numEvents":2}],"term":"Radiation pneumonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Road traffic accident"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Upper limb fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Acute myocardial infarction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Benign ovarian tumour"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Bowen's disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":143,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Colon cancer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Prostate cancer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Aortic valve disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Small intestine carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":143,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Cerebrovascular accident"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Prerenal failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Ureterolithiasis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Uterine prolapse"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Haemoptysis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Interstitial lung disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":143,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Myocardial infarction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":2}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":143,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Pneumonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":143,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Pneumothorax"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Pneumothorax spontaneous"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Pulmonary embolism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Myocardial ischaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":143,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":73,"numEvents":1}],"term":"Aortic aneurysm rupture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Deep vein thrombosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":143,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":73,"numEvents":0}],"term":"Venous thrombosis limb"}],"timeFrame":"From the time of signature of informed consent throughout the treatment period (maximum actual duration of 62.4 and 56.2 months for Osimertinib and Placebo respectively) up to and including 28 day follow up following last dose of study drug."}